Derivados selenados como terapia frente a cáncer, tripanosomas y otras patologías
SECALE
Jagiellonian University
Cracovia, PoloniaPublicaciones en colaboración con investigadores/as de Jagiellonian University (5)
2022
-
Pharmaceutical and Safety Profile Evaluation of Novel Selenocompounds with Noteworthy Anticancer Activity
Pharmaceutics, Vol. 14, Núm. 2
-
Synthesis of novel organic selenium compounds and speciation of their metabolites in biofortified kale sprouts
Microchemical Journal, Vol. 172
2019
-
Selenocompounds as novel antibacterial agents and bacterial efflux pump inhibitors
Molecules, Vol. 24, Núm. 8
2017
-
Selenoesters and selenoanhydrides as novel multidrug resistance reversing agents: A confirmation study in a colon cancer MDR cell line
Bioorganic and Medicinal Chemistry Letters, Vol. 27, Núm. 4, pp. 797-802
2016
-
Identification of selenocompounds with promising properties to reverse cancer multidrug resistance
Bioorganic and Medicinal Chemistry Letters, Vol. 26, Núm. 12, pp. 2821-2824